Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy

To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields. Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 200...

Full description

Saved in:
Bibliographic Details
Published inPractical radiation oncology
Main Authors Gao, Robert W, Tollefson, Matthew K, Thompson, R Houston, Potretzke, Aaron M, Quevedo, Fernando J, Choo, Richard, Davis, Brian J, Pisansky, Thomas M, Harmsen, W Scott, Stish, Bradley J
Format Journal Article
LanguageEnglish
Published United States 01.09.2021
Online AccessGet more information

Cover

Loading…
Abstract To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields. Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 2009 were analyzed for associations with outcomes. Sites of LRR from all patients with available imaging (39) were contoured on computed tomography image sets of patients with representative anatomy, and ART fields were proposed based on these distributions. A total of 279 patients with a median follow-up of 13.0 years were analyzed. The 5-year cumulative incidence of LRR was 16.7% (95% CI, 12.2-21). Pathologic risk factors (PRFs) associated with increased risk of LRR included tumor in both the renal pelvis and ureter, T stage ≥2, lymph node involvement, grade 3 histology, and positive surgical margins (P < .05). Patients with an increased number of PRFs had a significantly greater risk of LRR. The 5-year cumulative incidence estimates of LRR were 5.3% (95% CI, 1.8%-16.0%), 15.6% (95% CI, 9.5%-25.7%), and 43.9% (95% CI, 31.1%-62.1%) for those with 1, 2, and ≥3 PRFs, respectively. ART fields covering the renal fossa and retroperitoneal lymph nodes from the superior border of L1 through the aortic bifurcation would encompass all sites of LRR for 33 of 46 patients (72%). Non-LRR bladder and distant failure occurred in 101 (36.2%) and 73 (26.2%) of the patients, respectively. The 5-year cumulative incidence estimate of distant failure was 22.5% (95% CI, 17.4%-27.3%). In patients receiving nephroureterectomy for UTUC, LRR is significantly increased in patients with 2 or more PRFs. These data provide clinically valuable insight into the selection of candidates for ART and the design of ART fields.
AbstractList To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields. Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 2009 were analyzed for associations with outcomes. Sites of LRR from all patients with available imaging (39) were contoured on computed tomography image sets of patients with representative anatomy, and ART fields were proposed based on these distributions. A total of 279 patients with a median follow-up of 13.0 years were analyzed. The 5-year cumulative incidence of LRR was 16.7% (95% CI, 12.2-21). Pathologic risk factors (PRFs) associated with increased risk of LRR included tumor in both the renal pelvis and ureter, T stage ≥2, lymph node involvement, grade 3 histology, and positive surgical margins (P < .05). Patients with an increased number of PRFs had a significantly greater risk of LRR. The 5-year cumulative incidence estimates of LRR were 5.3% (95% CI, 1.8%-16.0%), 15.6% (95% CI, 9.5%-25.7%), and 43.9% (95% CI, 31.1%-62.1%) for those with 1, 2, and ≥3 PRFs, respectively. ART fields covering the renal fossa and retroperitoneal lymph nodes from the superior border of L1 through the aortic bifurcation would encompass all sites of LRR for 33 of 46 patients (72%). Non-LRR bladder and distant failure occurred in 101 (36.2%) and 73 (26.2%) of the patients, respectively. The 5-year cumulative incidence estimate of distant failure was 22.5% (95% CI, 17.4%-27.3%). In patients receiving nephroureterectomy for UTUC, LRR is significantly increased in patients with 2 or more PRFs. These data provide clinically valuable insight into the selection of candidates for ART and the design of ART fields.
Author Potretzke, Aaron M
Choo, Richard
Pisansky, Thomas M
Gao, Robert W
Harmsen, W Scott
Tollefson, Matthew K
Stish, Bradley J
Davis, Brian J
Thompson, R Houston
Quevedo, Fernando J
Author_xml – sequence: 1
  givenname: Robert W
  surname: Gao
  fullname: Gao, Robert W
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
– sequence: 2
  givenname: Matthew K
  surname: Tollefson
  fullname: Tollefson, Matthew K
  organization: Department of Urology, Mayo Clinic, Rochester, Minnesota
– sequence: 3
  givenname: R Houston
  surname: Thompson
  fullname: Thompson, R Houston
  organization: Department of Urology, Mayo Clinic, Rochester, Minnesota
– sequence: 4
  givenname: Aaron M
  surname: Potretzke
  fullname: Potretzke, Aaron M
  organization: Department of Urology, Mayo Clinic, Rochester, Minnesota
– sequence: 5
  givenname: Fernando J
  surname: Quevedo
  fullname: Quevedo, Fernando J
  organization: Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota
– sequence: 6
  givenname: Richard
  surname: Choo
  fullname: Choo, Richard
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
– sequence: 7
  givenname: Brian J
  surname: Davis
  fullname: Davis, Brian J
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
– sequence: 8
  givenname: Thomas M
  surname: Pisansky
  fullname: Pisansky, Thomas M
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
– sequence: 9
  givenname: W Scott
  surname: Harmsen
  fullname: Harmsen, W Scott
  organization: Department of Biostatistics & Information, Mayo Clinic, Rochester, Minnesota
– sequence: 10
  givenname: Bradley J
  surname: Stish
  fullname: Stish, Bradley J
  email: stish.bradley@mayo.edu
  organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: stish.bradley@mayo.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33636378$$D View this record in MEDLINE/PubMed
BookMark eNo1kN1Kw0AQhRdR_Km-gBeyL5C42fxflmpVKFpKi5dlujtptiS7YbIt9JV8SlOqzMXAnMP5hnPHLq2zyNhjJMJIRNnzLuyIXCiFjEIhQyHSC3YbFXkZFGlUXrObOM6GyYtb9jMn1EZ5Rz13FZ855Qi3xllo-ALVngitQg5W8xdsjEXwg3iyjvVufwDr-QK0OV-XNRJ0Rz412OieV474fFDQ-p5_G1_zVdch8SWB8nxFztdD5ACaACljXQsnJJqDsVv-iV1Nbk_okXD4rz3es6sKmh4f_vaIraavy8l7MPt6-5iMZ4GK08wHicohAdgolemikLkUCeiNznModRwVhcYyk6mUmzwWSVnFotSolEgLQMiSJJIj9nTO7fabFvW6I9MCHdf_pclfggBx0Q
CitedBy_id crossref_primary_10_4103_UROS_UROS_58_22
crossref_primary_10_1016_j_purol_2022_08_003
ContentType Journal Article
Copyright Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
DBID NPM
DOI 10.1016/j.prro.2021.02.005
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1879-8519
ExternalDocumentID 33636378
Genre Journal Article
GroupedDBID NPM
ID FETCH-LOGICAL-c356t-4c7a4aabcc6d8827204adbd77a9d3188de962522b73049f309decc058aea64412
IngestDate Wed Jun 21 02:24:41 EDT 2023
IsPeerReviewed true
IsScholarly true
Language English
License Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c356t-4c7a4aabcc6d8827204adbd77a9d3188de962522b73049f309decc058aea64412
PMID 33636378
ParticipantIDs pubmed_primary_33636378
PublicationCentury 2000
PublicationDate 2021-09-01
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Practical radiation oncology
PublicationTitleAlternate Pract Radiat Oncol
PublicationYear 2021
Score 2.2778645
Snippet To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose...
SourceID pubmed
SourceType Index Database
Title Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy
URI https://www.ncbi.nlm.nih.gov/pubmed/33636378
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitswEBXZFsq-lJbeb8xD34xLfJX1GJZuQyFhWRK6b4tkyWWXxjbGedlP6i_05zoj-bbptrQlYIJkR8FzkEZHM2cYe88TVczjQPkhF9KPVWp8GYbKF5qrpAiCIrPyxat1utzGny-Si9nsxyRqad-qD_nNnXkl_2NVbEO7UpbsP1h2-FFswO9oX7yihfH6VzY-a-iYxdbLIaq_IknKr47bOyce3SnIumBjcicH93Chr_foQrfeOUkT2NaNkxfwTimkzYo0kHz_lU2A-0Jk7bauTUNi6HnrbRtK3PpGbPsJFSMqq52kIc2V5SfWpqbyPw2F2tCpwO7W2bGTSCJsNMPoVZnf4vc_yWqM-_YGHmhDNEfRJYl1pcpHonYMbsEnvWW1J8d2mPurFv_PjYtFWsgGB11NKY8wGGK6cMVy03TGhY--orhzEXB8xDUuQQ2ld4adKmsyvRkNWe8sLKIoxY-rI_Tn3gNh7r7riB3xjKbY9dmqS8tyEYSH4x-zB_0zB5sY68xsHrGH3S4EFg5Sj9nMlE_Y9xFOUBUwhROMcAKEE0zgRLf2cIIBTtDBCRycAOEEPZyA4AQWTmDhBCOcYIATDHCCX-H0lG1PP25Oln5XysPPoyRt_TjnMpZS5XmqcU9HlZGkVppzKTSuKpk2AjfiOElwOvYtornQOLfMk0waSR57-IzdK6vSvGAQhCrNlZFZqpK4CKIs4SYzIteZFIUJxEv23L3ay9rptVz2L_3Vb3tes-MRZ2_Y_QInCPMWvc1WvbN2_QkMHIx4
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+Locoregional+Recurrence+and+Delineation+of+Adjuvant+Radiation+Therapy+Fields+for+Patients+With+Upper+Tract+Urothelial+Carcinoma+Receiving+Nephroureterectomy&rft.jtitle=Practical+radiation+oncology&rft.au=Gao%2C+Robert+W&rft.au=Tollefson%2C+Matthew+K&rft.au=Thompson%2C+R+Houston&rft.au=Potretzke%2C+Aaron+M&rft.date=2021-09-01&rft.eissn=1879-8519&rft_id=info:doi/10.1016%2Fj.prro.2021.02.005&rft_id=info%3Apmid%2F33636378&rft_id=info%3Apmid%2F33636378&rft.externalDocID=33636378